Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oren

Showing results (231-240 of 258) with videos related to

Pageof 26
Sort By:
The British Journal of Radiology|July 11, 1998
An economic evaluation of the use of rare earth screens to reduce the radiation dose from diagnostic X-ray procedures in IsraelG M Ginsberg, T Schlesinger, A Ben-Shlomo, et al.
Nature|August 29, 1996
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damageN Tanaka, M Ishihara, M S Lamphier, et al.
Cell Death and Differentiation|August 13, 2013
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescenceF Fausti, S Di Agostino, M Cioce, et al.
The British Journal of Dermatology|April 13, 2019
Usefulness of the 'two-step method' of digital follow-up for early-stage melanoma detection in high-risk French patients: a retrospective 4-year studyG Gasparini, N Madjlessi, J Delyon, et al.
The Journal of Biological Chemistry|July 8, 2000
Physical and functional interaction between p53 mutants and different isoforms of p73S Strano, E Munarriz, M Rossi, et al.
Cell Death and Differentiation|August 22, 2009
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYCN R Christoffersen, R Shalgi, L B Frankel, et al.
The Journal of Experimental Medicine|December 8, 1998
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugsM Müller, S Wilder, D Bannasch, et al.
The American Journal of Cardiology|September 3, 2004
Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)Clyde W Yancy, Mitchell T Saltzberg, Robert L Berkowitz, et al.
Cell Death and Differentiation|October 1, 2005
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinomaM Müller, T Schilling, A E Sayan, et al.
Oncogene|December 9, 2008
Cancer cells suppress p53 in adjacent fibroblastsJ Bar, R Feniger-Barish, N Lukashchuk, et al.
Pageof 26

Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
The British Journal of Radiology|July 11, 1998
An economic evaluation of the use of rare earth screens to reduce the radiation dose from diagnostic X-ray procedures in IsraelG M Ginsberg, T Schlesinger, A Ben-Shlomo, et al.
Nature|August 29, 1996
Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damageN Tanaka, M Ishihara, M S Lamphier, et al.
Cell Death and Differentiation|August 13, 2013
ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescenceF Fausti, S Di Agostino, M Cioce, et al.
The British Journal of Dermatology|April 13, 2019
Usefulness of the 'two-step method' of digital follow-up for early-stage melanoma detection in high-risk French patients: a retrospective 4-year studyG Gasparini, N Madjlessi, J Delyon, et al.
The Journal of Biological Chemistry|July 8, 2000
Physical and functional interaction between p53 mutants and different isoforms of p73S Strano, E Munarriz, M Rossi, et al.
Cell Death and Differentiation|August 22, 2009
p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYCN R Christoffersen, R Shalgi, L B Frankel, et al.
The Journal of Experimental Medicine|December 8, 1998
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugsM Müller, S Wilder, D Bannasch, et al.
The American Journal of Cardiology|September 3, 2004
Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial)Clyde W Yancy, Mitchell T Saltzberg, Robert L Berkowitz, et al.
Cell Death and Differentiation|October 1, 2005
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinomaM Müller, T Schilling, A E Sayan, et al.
Oncogene|December 9, 2008
Cancer cells suppress p53 in adjacent fibroblastsJ Bar, R Feniger-Barish, N Lukashchuk, et al.
Pageof 26